Randomized Phase 2 trial initiated for agenT-797 in severe acute lung injury and respiratory distress, with preliminary data expected in the ...

We can readily understand why investors are attracted to unprofitable companies. For example, although Amazon.com ...

Randomized Phase 2 trial evaluates off-the-shelf invariant natural killer T (iNKT) cell therapy in patients with acute lung injury and hypoxemic ...

Q1 2026 Management View Dr. Jennifer Buell (Co-Founder, President, CEO & Director) framed recent disclosures around clinical and mechanistic readouts across oncology and pulmonary indications, saying, ...

MiNK Therapeutics Inc (INKT) showcases promising clinical progress and strategic collaborations, while navigating financial hurdles and development risks.

It is interesting to see that Mink, the Icelandic funky camper brand, doesn’t once mention the word "caravan" in the press release for its upcoming Mink-E model. Perhaps that’s because it considers ...